Posted in Avonex, Betaseron, Copaxone, Diagnosis, Treatment • Tags: Avonex, Betaseron, Copaxone, Diagnosis, Treatment
By Groshan Fabiola
Despite the fact that there is no specific cure for multiple sclerosis in present, existing treatments are effective in slowing down the progression rate of the disease and preventing the development of further complications. Considering the fact that most of the effects of multiple sclerosis are irreversible, it is imperative to timely diagnose the disease and begin the administration of the appropriate course of medications. With the right treatment and with the aid of supportive therapies (physiotherapy and kinetotherapy), patients with multiple sclerosis can regain control of their bodies and live normal, active lives.
The medications available today are used to accomplish a series of goals in patients with multiple sclerosis: some medication treatments are aimed at slowing the progression rate of the disease, while others are aimed at ameliorating its generated symptoms and prolonging the periods of remission. The medications that are nowadays extensively used to delay and control symptomatic flare-ups among patients with multiple sclerosis are known as “ABC drugs”. This category of medications consists of Avonex, Betaseron and Copaxone.
More →
Share This
Posted on November 29, 2006 by HART (1-800-HART) • There are no comments, hop to it!
Posted in Copaxone, Lipitor • Tags: Copaxone, HELP, Lipitor, MS, STATINS, TO
17 March 2006
A DRUG to lower cholesterol could also help multiple sclerosis sufferers, say researchers.
Tests on mice with a similar auto-immune condition produced remarkable results when cholesterol busting statin Lipitor was combined with MS drug Copaxone.
It helped prevent or reduce paralysis, said scientists at the University of California and Stanford University Medical Center in California.
More →
Share This
Posted on March 22, 2006 by HART (1-800-HART) • There are no comments, hop to it!
Posted in Copaxone, Lipitor • Tags: Combined, Copaxone, Cut, Disease, Dosages, Drug, Effects, Fewer, Half, in, Lipitor, May, Multiple, Negative, or, Reverse, Sclerosis, Side, Stop, with
March 16th 2006
Combining treatments may improve outcomes for patients with Multiple Sclerosis (MS), according to research done on mice and published online by the Journal of Clinical Investigation. Scott S. Zamvil and colleagues at the University of California, San Francisco found that mice treated with a combination of Glatiramer acetate (GA) and atorvastatin (Lipitor) demonstrated “a significant prevention and reversal of clinical MS severity” of MS symptoms.
Lipitor is a cholesterol lowering drug that has previously been shown to improve MS symptoms. Glatiramer acetate (Teva Pharmaceutical Industries Ltd.’s Copaxone) is a drug currently approved for MS treatment. The researchers found that treating MS with combinations of immune modulating drugs can greatly reduce MS disease.
More →
Share This
Posted on March 22, 2006 by HART (1-800-HART) • There are no comments, hop to it!